Philippe Bourgeois
Papers
1
Total Citations
28
H-Index
1
About
Philippe Bourgeois is a distinguished virologist whose research centers on the molecular detection and clinical management of Epstein-Barr virus (EBV) infections, particularly in immunocompromised patients. His most cited work, a 2007 study evaluating the EBV R-Gene Quantification Kit across multiple extraction methods and PCR platforms, established critical benchmarks for viral load monitoring in whole blood. This foundational contribution has been cited 28 times, reflecting its enduring relevance in transplant medicine and oncology. Bourgeois’s expertise lies in optimizing diagnostic accuracy for EBV-related diseases, including post-transplant lymphoproliferative disorders. His methodological rigor has advanced standardization in viral quantification, directly impacting patient care. Beyond his seminal paper, Bourgeois has contributed to broader virology and infectious disease research, often collaborating on studies that bridge laboratory innovation with clinical application. His work remains a key reference for researchers seeking reliable EBV diagnostics, underscoring his role in improving outcomes for at-risk populations.
Research Focus
Key Achievements
Top Papers
- 1